Wound Treatments - Romania

May 2010 | 37 pages | ID: WA8B18C9A2AEN
Euromonitor International Ltd

Abstracts

Wound treatments did not gain significant share within consumer healthcare in 2009. The fact that household usage was for minor wounds, and major cases were treated by specialists in hospitals or polyclinics, limited volume growth. The good volume and current value growth rate in 2009 of 9% was caused by the improved quality of wound treatments and unit price growth, supported by higher household incomes. Sticking plasters are amongst the few consumer healthcare products which have a strong...

Euromonitor International's Wound Treatments Products in Romania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.

Product coverage: Other Wound Treatments, Sticking Plasters

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health industry;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Wound Treatments in Romania
Euromonitor International
May 2010

LIST OF CONTENTS AND TABLES

Executive Summary
Self-medication Is on the Increase
Growth Slows Down in Context of the Economic Situation
Consumer Healthcare Is Dominated by Domestic Producers
Chemists/pharmacies Maintains Its Dominance
Changing Lifestyles Increase Consumer Healthcare Consumption
Key Trends and Developments
Ageing Population Impacts Consumer Healthcare's Performance
Changes in Consumer Lifestyle Encourages More Self-medication
Consumer Healthcare Remains Highly Regulated
Modernisation of Pharmacies Contributes To Sales Growth
Domestic Producers Lead Consumer Healthcare
Rural Areas Represent Strong Growth Potential
Market Indicators
  Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
  Table 2 Life Expectancy at Birth 2004-2009
Market Data
  Table 3 Sales of Consumer Health by Sector: Value 2004-2009
  Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
  Table 5 Consumer Health Company Shares by Value 2005-2009
  Table 6 Consumer Health Brand Shares by Value 2006-2009
  Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
  Table 8 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
  Table 9 Forecast Sales of Consumer Health by Sector: Value 2009-2014
  Table 10 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Generics
Switches
  Summary 1 OTC Healthcare Switches 2005-2009
Definitions
Analgesics
Cough, Cold and Allergy (hay Fever) Remedies
Digestive Remedies
Medicated Skin Care
Nrt Smoking Cessation Aids
Eye Care
Ear Care
Adult Mouth Care
Calming and Sleeping Products
Wound Treatments
OTC Obesity
Emergency Contraception
OTC Statins
OTC Triptans
Vitamins and Dietary Supplements
Slimming Products
Sports Nutrition Products
Herbal/traditional Products
  Summary 2 Research Sources
Antibiotice SA
Strategic Direction
Key Facts
  Summary 3 Antibiotice SA: Key Facts
  Summary 4 Antibiotice SA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 5 Antibiotice SA: Competitive Position 2009
Biofarm SA
Strategic Direction
Key Facts
  Summary 6 Biofarm SA: Key Facts
  Summary 7 Biofarm SA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 8 Biofarm SA: Competitive Position 2009
Ozone Laboratories SRL
Strategic Direction
Key Facts
  Summary 9 Ozone Laboratories SRL: Key Facts
  Summary 10 Ozone Laboratories SRL: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 11 Ozone Laboratories SRL: Competitive Position 2009
Terapia Ranbaxy
Strategic Direction
Key Facts
  Summary 12 Terapia Ranbaxy: Key Facts
  Summary 13 Terapia Ranbaxy: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 14 Terapia Ranbaxy: Competitive Position 2009
Zentiva SA
Strategic Direction
Key Facts
  Summary 15 Zentiva SA: Key Facts
  Summary 16 Zentiva SA: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 17 Zentiva SA: Competitive Position 2009
Trends
Category Data
  Table 11 Sales of Wound Treatments by Subsector: Value 2004-2009
  Table 12 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
  Table 13 Wound Treatments Company Shares by Value 2005-2009
  Table 14 Wound Treatments Brand Shares by Value 2006-2009
  Table 15 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
  Table 16 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014